Status:
RECRUITING
Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Obstructive Sleep Apnea of Adult
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea syndrome (OSA) is marked by repeated upper airway obstructions during sleep, affecting approximately 14% of men and 5% of women aged 30-70 years. However, precise clinical pre...
Detailed Description
Backgrounds: Obstructive sleep apnea syndrome (OSA) is marked by repeated upper airway obstructions during sleep, affecting about 14% of men and 5% of women aged 30-70 years. The etiology of OSA is d...
Eligibility Criteria
Inclusion
- OSA patients
- Aged over 20 years
Exclusion
- BMI≧ 32
- Central or mixed types of sleep apnea
- A history of malignancy or infection of the head and neck region and laryngeal trauma
- Craniofacial malformation
- Stroke
- Neuromuscular disease
- Severe cardiovascular disease
- Active psychiatric disease
- Structural abnormalities over the upper respiratory airway
- Performed any operation or treatment over the neck before
- Pregnancy
Key Trial Info
Start Date :
July 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06512779
Start Date
July 30 2024
End Date
May 1 2026
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan, 701